Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

Thread starter U.S. News
Start date Jul 9, 2025

U.S. News

Guest

Jul 9, 2025

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a maintenance fee in 2019.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

Prefix: N/A

Forum: USA News

Start date: Jul 9, 2025

Last reply date: Jul 9, 2025

Replies: 0

Thread Tags

Thread statistics

Created: U.S. News, Jul 9, 2025

Replies: 0

Views: 23

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search